Pathway-directed weighted testing procedures for the integrative analysis of gene expression and metabolomic data

Genomics

Volumn 99, Issue 5, 2012, Pages 265-274

  Poisson, Laila M ^a   Sreekumar, Arun ^b   Chinnaiyan, Arul M ^c   Ghosh, Debashis ^d  

^a HENRY FORD HOSPITAL   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^d PENNSYLVANIA STATE UNIVERSITY   (United States)

Author keywords

Cancer; Metabolomic data; Multiple testing; Pathway information; Transcriptomic data

Indexed keywords

AMINO ACID ANALYSIS; ARTICLE; CANCER GENETICS; CONTROLLED STUDY; GENE EXPRESSION; GENE MAPPING; GENOME ANALYSIS; METABOLISM; METABOLITE; METABOLOMICS; PRIORITY JOURNAL; PROCESS DEVELOPMENT; PROCESS MODEL; PROSTATE CANCER; STATISTICAL MODEL; STATISTICAL SIGNIFICANCE; SYSTEMATIC ERROR;

ALGORITHMS; COMPUTER SIMULATION; GENE EXPRESSION PROFILING; HUMANS; MALE; METABOLOMICS; PROSTATIC NEOPLASMS; REPRODUCIBILITY OF RESULTS;

EID: 84860696573     PISSN: 08887543     EISSN: 10898646     Source Type: Journal    
DOI: 10.1016/j.ygeno.2012.03.004     Document Type: Article

References (34)

1. Mathew J., Taylor B., Bader G., Pyarajan S., Antoniotti M., Chinnaiyan A., Sander C., Burakoff S., Mishra B. From bytes to bedside: data integration and computational biology for translational cancer research. PLoS Comput. Biol. 2007, 3(2):e12.
2. Network T.C.G.A. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature 2008, 255:1061-1068.
3. Spratlin J., Serkova N., Eckhardt S. Clinical applications of metabolomics in oncology: a review. Clin. Cancer Res. 2009, 15:431-440.
4. Sreekumar A., Poisson L., Rajendiran T., Khan A., Cao Q., Yu J., Laxman B., Mehra R., Lonigro R., Li Y., Nyati M., Ahsan A., Kalyana-Sundaram S., Han B., Cao X., Byun J., Omenn G., Ghosh D., Pennathur S., Alexander D., Berger A., Shuster J., Wei J., Varambally S., Beecher C., Chinnaiyan A. Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression. Nature 2009, 457(7231):910-914.
5. Blekherman R., ad Laubenbacher G., Cortes D., Mendes P., Torti F., Akman S., Torti S., Shulaev V. Bioinformatics tools for cancer metabolomics. Metabolomics 2011, 7:329-343.
6. Yeang C.-H. Integration of metabolomic reactions and gene regulation. Mol. Biotechnol. 2011, 47:70-82.
7. Casado-Vela J., Cebrian A., Gomez del Pulgar M., Lacal J. Approaches for the study of cancer: towards the integration of genomics, proteomics and metabolomics. Clin. Transl. Oncol. 2011, 13:617-628.
8. Karnovsky A., Weymouth T., Hull T., Tarcea V., Scardoni G., Laudanna C., Sartor M., Stringer K., Jagadish H., Burant C., Athey B., Omenn G. Metscape 2 bioinformatics tool for the analysis and visualization of metabolomics and gene expression data. Bioinformatics 2012, 28:373-380.
9. Symons S., Nieselt K. Mgv: a generic graph viewer for comparative omics data. Bioinformatics 2011, 27:2248-2255.
10. Garcia-Alcalde F., García-López F., Dopazo J., Conesa A. Paintomics: a web based tool for the joint visualization of transcriptomics and metabolomics data. Bioinformatics 2011, 27(1):137-139.
11. Hirai M., Klein M., Fujikawa Y., Yano M., Goodenowe D.B., Yamazaki Y., Kanaya S., Nakamura Y., Kitayama M., Suzuki H., Sakurai N., Shibata D., Tokuhisa J., Reichelt M., Gershenzon J., Papenbrock J., Saito K. Elucidation of gene-to-gene and metabolite-to-gene networks in arabidopsis by integration of metabolomics and transcriptomics. J. Biol. Chem. 2005, 280(27):25590-25595.
12. Weckwerth W. Integration of metabolomics and proteomics in molecular plant physiology - coping with the complexity by data-dimensionality reduction. Physiol. Plant. 2008, 132:176-189.
13. Ippolito J., Xu J., Jian S., Moulder K., Mennerick S., Crowlery J., Townsend R., Gordon J. An integrated functional genomics and metabolomics approach for defining poor prognosis in human neuroendocrine cancers. Proc. Natl. Acad. Sci. U. S. A. 2005, 102(28):9901-9906.
14. Goodacre R., Vaidyanathan S., Dunn W., Harrigan G., Kell D. Metabolomics by numbers: acquiring and understanding global metabolite data. Trends Biotechnol. 2004, 22(5):245-252.
15. Connor S., Hansen M., Corner A., Smith R., Ryan T. Integration of metabolomics and transcriptomics data to aid biomarker discovery in type 2 diabetes. Mol. Biosyst. 2010, 6:909-921.
16. Van Deun K., Wilderjans T., van den Berg R., Antoniadis A., Van Mechelen I. A flexible framework for sparse simultaneous component based data integration. BMC Bioinformatics 2011, 448.
17. Le Cao K.-A., Rossouw D., Robert-Granie C., Besse P. A sparse pls for variable selection when integrating omics data. Stat. Appl. Genet. Mol. Biol. 2008, 7. Article 35.
18. Genovese C.R., Roeder K., Wasserman L. False discovery control with p-value weighting. Biometrika 2006, 93(3):509-524.
19. Kanehisa M., Goto S. KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 2000, 28:27-30.
20. Kanehisa M., Goto S., Hattori M., Aoki-Kinoshita K., Itoh M., Kawashima S., Katayama T., Araki M., Hirakawa M. From genomics to chemical genomics: new developments in KEGG. Nucleic Acids Res. 2006, 34:354-357.
21. Kanehisa M., Araki M., Goto S., Hattori M., Hirakawa M., Itoh M., Katayama T., Kawashima S., Okuda S., Tokimatsu T., Yamanishi Y. KEGG for linking genomes to life and the environment. Nucleic Acids Res. 2008, 36:480-484.
22. Holm S. A simple sequentially rejective multiple test procedure. Scand. J. Stat. 1979, 6:65-70.
23. Benjamini Y., Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Stat. Soc. B 1995, 57:289-300.
24. Roeder K., Bacanu S., Wasserman L., Devlin B. Using linkage genome scans to improve power of association in genome scans. Am. J. Hum. Genet. 2006, 78:243-252.
25. Walsh M., Brennan L., Malthouse J., Roche H., Gibney M. Effect of acute dietary standardization on the urinary, plasma, and salivary metabolomic profiles of healthy humans. Am. J. Clin. Nutr. 2006, 84:531-539.
26. Zivkoic A., German J. Metabolomics for assessment of nutritional status. Curr. Opin. Clin. Nutr. Metab. Care 2009, 12:501-507.
27. Minami Y., Kasukawa T., Kakazu Y., Iigo M., Sugimoto M., Ikeda S., Yasui A., van der Horst G., Soga T., Ueda H. Measurement of internal body time by blood metabolomics. Proc. Natl. Acad. Sci. U. S. A. 2009, 106(2):9890-9895.
28. Goeman J., Bühlmann P. Analyzing gene expression data in terms of gene sets: methodological issues. Bioinformatics 2007, 23(8):980-987.
29. Subramanian A., Tamayo P., Mootha V., Mukherjee S., Ebert B., Gillette M., Paulovich A., Pomeroy S., Golub T., Lander E., Mesirov J. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:15545-15550.
30. Ackermann M., Strimmer K. A general modular framework for gene set enrichment analysis. BMC Bioinformatics 2009, 10:47.
31. Varambally S., Yu J., Laxman B., Rhodes D., Mehra R., Tomlins S., Shah R., Chandran U., Monzon F., Becich M., Wei J., Pienta K., Ghosh D., Rubin M., Chinnaiyan A. Integrative genomic and proteomic analysis of prostate cancer reveals signatures of metastatic progression. Cancer Cell 2005, 8:393-406.
32. Trock B. Application of metabolomics to prostate cancer. Urol. Oncol. 2011, 29:572-581.
33. Kojima S., Chiyomaru T., Kawakami K., Yoshino H., Enokida H., Nohata N., Fuse M., Ichikawa T., Naya Y., Nakagawa M., Seki N. Tumour suppressors mir-1 and mir-133a target the oncogenic function of purine nucleoside phosphorylase (pnp) in prostate cancer. Br J Cancer 2012, 106(2):405-413.
34. Vareed S., Bhat V., Thompson C., Vasu V., Fermin D., Choi H., Creighton C., Gayatri S., Lan L., Putluri N., Thangjam G., Kaur P., Shabahang M., Giri J., Nesvizhskii A., Asea A., Cashikar A., Rao A., McLoughlin J., Sreekumar A. Metabolites of purine nucleoside phosphorylase (np) in serum have the potential to delineate pancreatic adenocarcinoma. PLoS One 2011, 6:e17177.